Early- versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 years

Early- versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 years

Abstract Background Whether age at onset influences Alzheimer’s disease (AD) progression and the effectiveness of cholinesterase inhibitor (ChEI) therapy is not clear. We aimed to compare longitudinal cognitive and global outcomes in ChEI-treated patients with early-onset Alzheimer’s disease (EOAD)...

Full description

Bibliographic Details
Main Authors: Carina Wattmo, Åsa K. Wallin
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Alzheimer’s Research & Therapy
Subjects:
Cognition
Cholinesterase inhibitors
Early-onset Alzheimer’s disease
Late-onset Alzheimer’s disease
Predictors
Longitudinal study
Online Access:http://link.springer.com/article/10.1186/s13195-017-0294-2

Internet

http://link.springer.com/article/10.1186/s13195-017-0294-2

Similar Items